BlueCrest Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-15,928
Closed -$282K – 1102
2017
Q1
$282K Buy
15,928
+3,869
+32% +$71.8K 0.01% 540
2016
Q4
$179K Sell
12,059
-20,615
-63% -$370K 0.01% 617
2016
Q3
$740K Buy
+32,674
New +$850K 0.02% 433
2016
Q2
– Sell
-16,682
Closed -$483K – 1042
2016
Q1
$483K Buy
+16,682
New +$434K 0.03% 511
2015
Q4
– Sell
-15,041
Closed -$555K – 1166
2015
Q3
$555K Sell
15,041
-23,218
-61% -$1.2M 0.02% 571
2015
Q2
$2.21M Buy
+38,259
New +$1.95M 0.06% 319
2015
Q1
– Sell
-14,228
Closed -$721K – 746
2014
Q4
$721K Buy
+14,228
New +$744K 0.02% 413

Other funds holding THC

BlueCrest Capital Management's THC Position: Q2 2017 in Review

BlueCrest Capital Management sold out of Tenet Healthcare (THC) in Q2 2017, closing a stake of 15,928 shares — an estimated $282K sold.

BlueCrest Capital Management first reported a position in THC in Q4 2014 and held it in 7 quarters. The position peaked at $2.21M in Q2 2015. 246 funds tracked by Wall St. Rank hold THC as of Q2 2017.

  • BlueCrest Capital Management reported no remaining Tenet Healthcare position as of Q2 2017 after selling out during the quarter.
  • BlueCrest Capital Management sold 15,928 Tenet Healthcare shares in Q2 2017, an estimated $282K.
  • BlueCrest Capital Management first reported a position in Tenet Healthcare in Q4 2014 and held it in 7 quarters.
  • BlueCrest Capital Management's Tenet Healthcare position peaked at $2.21M in Q2 2015.
  • 246 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2017.

Based on BlueCrest Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.